Taming glutathione potentiates metallodrug action

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Pharmacology

Background:

• Metallodrugs with redox-sensitive or labile coordination sites face deactivation by endogenous thiols like glutathione (GSH).
• Glutathione (GSH) is a critical antioxidant, necessitating careful consideration of its role in metallodrug efficacy.
• Thiol inhibition can significantly impact the therapeutic potential of metallodrugs.

Purpose of the Study:

• To review general strategies for mitigating glutathione (GSH) related deactivation of metallodrugs.
• To analyze the strengths and limitations of current approaches to prevent thiol inhibition.
• To provide perspectives on developing clinically relevant and effective solutions for metallodrug therapy.

Main Methods:

• Literature review of existing strategies for managing thiol interactions in metallodrugs.
• Analysis of the biochemical mechanisms underlying metallodrug-thiol interactions.
• Discussion of the clinical implications and potential of various anti-thiolation strategies.

Main Results:

• Several approaches exist to 'tame' glutathione (GSH) and prevent its inhibitory effects on metallodrugs.
• Each strategy presents unique advantages and disadvantages regarding efficacy and impact on normal cellular processes.
• Balancing thiol deactivation prevention with the preservation of essential antioxidant functions is a key challenge.

Conclusions:

• Developing effective metallodrug therapies requires addressing glutathione (GSH) mediated deactivation.
• Careful design and strategic implementation are crucial to overcome thiol inhibition.
• Future research should focus on practical, clinically applicable solutions that are both potent and safe.